항호르몬요법 중인 유방암 환자의 약물복용이행에 영향을 미치는 요인
Predictive Factors for Medication Adherence in Patients with Breast Cancer on Hormone Therapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of the study was to identify degrees of symptoms, self-efficacy, fear of cancer recurrence, anti-hormone therapy beliefs, and medication adherence, and to pinpoint factors influencing medication adherence among patients with breast cancer who were undergoing hormone therapy. Methods: The data of 144 breast cancer patients who had breast cancer surgery and were undergoing anti-hormone therapy were collected from July to August 2022. The collected data were analyzed using the descriptive statistics, t-test, ANOVA, Pearson’s correlation coefficients, and hierarchy multiple regression analysis. Results: Medication adherence significantly differed according to the breast cancer stage (F=3.35, p=.38) and presence of comorbidities other than breast cancer (t=-2.26, p=.025). Medication adherence was explained by breast cancer stage (β=.15), the presence of comorbidities other than breast cancer (β=.16), symptom (β=.17), and Anti-Hormone Therapy Beliefs (β=-.44)(F=11.47, p<.001). The model explained 34% of the variance. Conclusion: The results of the study suggest that share the patient’s symptom experiences among medical staff, and educate about the importance of anti-hormone therapy beliefs and prior methods. The findings of this study highlight the need to develop and implement education or interventions to enhance medication adherence among breast cancer patients who are undergoing anti-hormone therapy.
Abstract
Purpose: The purpose of the study was to identify degrees of symptoms, self-efficacy, fear of cancer recurrence, anti-hormone therapy beliefs, and medication adherence, and to pinpoint factors influencing medication adherence among patients with breast cancer who were undergoing hormone therapy. Methods: The data of 144 breast cancer patients who had breast cancer surgery and were undergoing anti-hormone therapy were collected from July to August 2022. The collected data were analyzed using the descriptive statistics, t-test, ANOVA, Pearson’s correlation coefficients, and hierarchy multiple regression analysis. Results: Medication adherence significantly differed according to the breast cancer stage (F=3.35, p=.38) and presence of comorbidities other than breast cancer (t=-2.26, p=.025). Medication adherence was explained by breast cancer stage (β=.15), the presence of comorbidities other than breast cancer (β=.16), symptom (β=.17), and Anti-Hormone Therapy Beliefs (β=-.44)(F=11.47, p<.001). The model explained 34% of the variance. Conclusion: The results of the study suggest that share the patient’s symptom experiences among medical staff, and educate about the importance of anti-hormone therapy beliefs and prior methods. The findings of this study highlight the need to develop and implement education or interventions to enhance medication adherence among breast cancer patients who are undergoing anti-hormone therapy.
참고문헌 (30)
- "Annual report of cancer statistics in Korea in 2020"[URL]
- 최정은, "Breast Cancer Statistics in Korea, 2019", Journal of Breast Cancer, 26(3), pp.207~220 (2023), 한국유방암학회[DOI]
- Woo JH, "Endocrine therapy for breast cancer", Ewha Med J, 37, pp.83~91 (2014)
- "Breast cancer facts & figures 2022"[URL]
- Gradishar WJ, "Invasive breast cancer version 1. 2017 NCCN clinical practice guidelines in oncology", J Natl Compr Canc Netw, 14, pp.324~354 (2016)
- Burstein HJ, "Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer : American Society of Clinical Oncology clinical practice guideline focused update", J Clin Oncol, 32, pp.2255~2269 (2014)
- Guedes JB, "Factors associated with adherence and persistence to hormonal therapy in women with breast cancer", Rev Bras Epidemiol, 20, pp.636~649 (2017)
- Ayres LR, "Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer", Int J Clin Pharm, 36, pp.45~54 (2014)
- Shelby RA, "Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy(AET)", Contemp Clin Trials, 76, pp.120~131 (2019)
- Yussof I, "Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients : a systematic review", Breast, 62, pp.22~35 (2022)
- Kim EJ, "Influencing factors on medication of adherence to adjuvant endocrine therapy for breast cancer", master, pp.2018
- Kim SH, "Factors influencing hormone therapy adherence among postoperative breast cancer patients", master, pp.2019
- Foulon V, "Patient adherence to oral anticancer drugs : an emerging issue in modern oncology", Acta Clin Belg, 66, pp.85~96 (2011)
- Lebel S, "From normal response to clinical problem : definition and clinical features of fear of cancer recurrence", Support Care Cancer, 24, pp.3265~3268 (2016)
- Simard S, "Fear of cancer recurrence in adult cancer survivors : a systematic review of quantitative studies", J Cancer Surviv, 7, pp.300~322 (2013)
- Crist JV, "Factors reported to influence fear of recurrence in cancer patients : a systematic review", Psychooncology, 22, pp.978~986 (2013)
- Horne R, "Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness", J Psychosom Res, 47, pp.555~567 (1999)
- Lee JY, "Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer", BMC Womens Health, 18, pp.48~ (2018)
- Lee JY, "Symptom clusters, medication adherence, and quality of life among breast cancer patients on hormone therapy", master, pp.2018
- 이란, "유방암 환자의 자가관리에 대한 자기효능감 측정도구 개발", Journal of Korean Academy of Nursing, 42(3), pp.385~395 (2012), 한국간호과학회
- Simard S, "Fear of Cancer Recurrence Inventory : development and initial validation of a multidimensional measure of fear of cancer recurrence", Support Care Cancer, 17, pp.241~251 (2009)
- 신진영, "Validation Study for the Korean Version of Fear of Cancer Recurrence Inventory", Journal of Korean Medical Science, 32(11), pp.1792~1799 (2017), 대한의학회
- Kim SH, "Development of an adjuvant endocrine therapy beliefs scale for breast cancer survivors", pp.2019
- Kripalani S, "Development and evaluation of the Adherence to Refills and Medications Scale(ARMS)among low-literacy patients with chronic disease", Value Health, 12, pp.118~123 (2009)
- Kim CJ, "Psychometric evaluation of a Korean version of the adherence to refills and medications scale (ARMS) in adults with type 2 diabetes", Diabetes Educ, 42, pp.188~198 (2016)
- 김효진, "유방암 환자의 증상경험 영향요인: 불쾌증상이론을 중심으로", Asian Oncology Nursing, 14(1), pp.7~14 (2014), 대한종양간호학회
- Huber C, "Sexuality and intimacy issues facing women with breast cancer", Oncol Nurs Forum, 33, pp.1163~1167 (2006)
- Seo YK, "Associating factors of aromatase inhibitor continuation intention among breast cancer survivors: focused on musculoskeletal pain", master, pp.2020
- Hartigan K, "Patient education : the cornerstone of successful oral chemotherapy treatment", Clin J Oncol Nurs, 7, pp.21~24 (2003)
- Lambert LK, "Understanding adjuvant endocrine therapy persistence in breast cancer survivors", BMC Cancer, 18, pp.732~ (2018)